您当前的位置:国际号刊-半年刊 > 内科学 >
国际心律杂志(英文)(International Journal of Heart Rhythm)(国际刊号)

国际心律杂志(英文)(International Journal of Heart Rhythm)(国际刊号)

基本信息
  • 主管单位:

  • 主办单位:

    国家心血管病中心(学术支持单位)

  • 国际刊号:

    2352-4197;EISSN2352-4200

  • 国内刊号:

  • 学科分类:

    内科学

  • 字数:

    -

  • 有无基金:

     

  • 周期:

    国际号刊-半年刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

  • 邮箱:

    editor@ijhronline.com(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

  • 级别:

期刊简介

《国际心律杂志(英文)(International Journal of Heart Rhythm)(国际刊号)》期刊已被查看:

更新频次

单位占比

一作占比

投稿指南

1、该刊只有国际刊号。

2、投稿方式:在线投稿。

3、官网网址:https://www.ijhronline.org/

自动跳转至:

https://journals.lww.com/ijhr/pages/default.aspx

4、投稿系统:https://review.jow.medknow.com/ijhr

5、官网邮箱:editor@ijhronline.com

6、出刊日期:半年刊,一年出版2期。

2024年4月26日星期五

《国际心律杂志(英文)》期刊简介

(International Journal of Heart Rhythm)

该杂志由著名国际出版集团Wolters Kluwer HealthTM 负责出版发行,邀请国家心血管病中心阜外医院心内科主任、心律失常中心主任,中国医师协会心律学专业委员会主任委员张澍教授担任首任主编,国家心血管病中心为学术支持单位,并分别邀请了副主编,美国的Michael R. Gold教授(Heart Rhythm Society副主席)、Douglas L. Packer教授(Heart Rhythm Society前任主席)、德国的Karl-Heinz Kuck教授(欧洲心律学会主席),G. Hindricks教授(欧洲心律学会候任主席),中国的黄从新教授(中华医学会心电生理和起搏分会主任委员)、陈适安教授(中国台湾,亚太心律学会前任主席)、CP. Lau教授(中国香港,香港心脏协会前任主席)和日本的Wataru Shimizu教授。国际编委会成员聚集了中国及全球的40位著名专家。其中8位来自美国,13 位来自欧洲,18 位来自中国(包括香港和台湾),8位来自亚洲其他国家,5位来自拉美等地区。

这份杂志的办刊目标是建立一个全球心律失常、心电生理医师交流临床实践和研究最新进展的国际化论坛,并通过发表有价值的论文,促进心律失常治疗领先国家与新兴地区间的学术交流和共同发展。杂志是公开获取的刊物,采用同行评审方式进行审稿,研究领域涵盖了心血管病临床、电生理和射频消融、心律失常器械治疗及基础研究。该杂志的创刊也将会帮助我国学者发表英文国际论文。

《国际心律杂志(英文)》

(International Journal of Heart Rhythm)作者须知

【官网信息】

Instructions to the Authors

About the Journal

International Journal of Heart Rhythm (IJHR) is an international journal for cardiologists to discuss the latest clinical findings in electrophysiology and arrhythmia treatments. The aim of this journal is to publish papers with strong and practical messages that advance EP knowledge and better patient care to bridge the gap between emerging countries and advanced countries. The journal’s full text is available online at http://www.ijhronline.com. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs.

Scope of the Journal

International Journal of Heart Rhythm publishes original articles, case reports, editorials and commentaries, as well as review articles, embracing studies from both fundamental and applied research in the field of arrhythmia treatments.

The Editorial Process

A manuscript will be reviewed for possible publication with the understanding that it is being submitted to International Journal of Heart Rhythm (IJHR) alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the International Journal of Heart Rhythm (IJHR) readers are also liable to be rejected at this stage itself.

Manuscripts received from Editorial Board members will be screened by the Editor-in-chief and sent to external peer reviewers. In case, Editor-in-chief is the author, then the article will be screened by Assistant editor/co-editor in chief and sent to external peer reviewers. The editorial board members who are authors will be excluded from publication decisions.

Manuscripts that are found suitable for publication in International Journal of Heart Rhythm (IJHR) are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. The author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process may be repeated till the manuscript is accepted.

Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ immediately on acceptance.

Appeal Procedure  

The authors do have the right to appeal if they have a genuine cause to believe that the editorial board has wrongly rejected the paper. If the authors wish to appeal the decision, they should email the editorial office (editor@ijhronline.org) explaining in detail the reason for the appeal. The appeals will be acknowledged by the editorial office and will be investigated in an unbiased manner. The processing of appeals will be done within 6–8 weeks. While under appeal, the said manuscript should not be submitted to other journals. The final decision rests with the Editor-in-Chief of the journal. Second appeals are not considered.

Clinical Trial Registry

International Journal of Heart Rhythm (IJHR) would publish clinical trials that have been registered with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable: http://www.ctri.in/; http://www.actr.org.au/; http://www.clinicaltrials.gov/; http://isrctn.org/; http://www.trialregister.nl/trialreg/index.asp; and http://www.umin.ac.jp/ctr. This is applicable to clinical trials that have begun enrollment of subjects in or after June 2008. Clinical trials that have commenced enrollment of subjects prior to June 2008 would be considered for publication in International Journal of Heart Rhythm (IJHR) only if they have been registered retrospectively with clinical trial registry that allows unhindered online access to public without charging any fees.

Authorship Criteria

Authorship credit should be based only on substantial contributions to each of the three components mentioned below:

Concept and design of study or acquisition of data or analysis and interpretation of data;

Drafting the article or revising it critically for important intellectual content; and

Final approval of the version to be published.

Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors. The journal prescribes a maximum number of authors for manuscripts depending upon the type of manuscript, its scope and number of institutions involved (vide infra). The authors should provide a justification, if the number of authors exceeds these limits.

Contribution Details

Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. Authors' contributions will be printed along with the article. One or more author should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as 'guarantor'.

Conflicts of Interest/ Competing Interests

All authors of articles must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript.

Submission of Manuscripts

All manuscripts must be submitted on-line through the website https://review.jow.medknow.com/ijhr. First time users will have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their user name and password. Authors do not have to pay for submission, processing or publication of articles. If you experience any problems, please contact the editorial office by e-mail at editor@ijhronline.com

……

更多详情:

https://journals.lww.com/ijhr/pages/informationforauthors.aspx

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。